• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD40/CD40L 和干扰素调节因子 4 在霍奇金淋巴瘤微环境中的作用。

The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment.

机构信息

Experimental Oncology, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano, PN, Italy.

出版信息

Leuk Lymphoma. 2012 Feb;53(2):195-201. doi: 10.3109/10428194.2011.605190. Epub 2011 Aug 24.

DOI:10.3109/10428194.2011.605190
PMID:21756027
Abstract

Inflammation and cancer are two independent biological events that can play an interdependent role. The model of such interaction is represented by Hodgkin lymphoma (HL), where the microenvironment is dominated by an extensive mixed, potentially cellular inflammatory infiltrate that plays a decisive role in the pathobiology of HL. In this review we summarize updated information on the complex interactions between Hodgkin Reed-Sternberg (HRS) cells and their tissue microenvironment, highlighting the functional role of CD40/CD40L and interferon regulatory factor 4 (IRF4).

摘要

炎症和癌症是两种独立的生物学事件,它们可以相互作用。这种相互作用的模型以霍奇金淋巴瘤(HL)为代表,其中微环境主要由广泛的混合、潜在的细胞炎症浸润组成,在 HL 的病理生物学中起着决定性的作用。在这篇综述中,我们总结了霍奇金氏 Reed-Sternberg(HRS)细胞与其组织微环境之间复杂相互作用的最新信息,强调了 CD40/CD40L 和干扰素调节因子 4(IRF4)的功能作用。

相似文献

1
The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment.CD40/CD40L 和干扰素调节因子 4 在霍奇金淋巴瘤微环境中的作用。
Leuk Lymphoma. 2012 Feb;53(2):195-201. doi: 10.3109/10428194.2011.605190. Epub 2011 Aug 24.
2
IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma.IRF4 的表达受 CD40L 以及霍奇金淋巴瘤中凋亡和抗增殖信号的调节。
Br J Haematol. 2010 Jan;148(1):115-8. doi: 10.1111/j.1365-2141.2009.07945.x. Epub 2009 Oct 11.
3
CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.血液系统恶性肿瘤中的CD40配体(CD154)和肿瘤坏死因子相关凋亡诱导配体(Apo-2L)
Br J Haematol. 2001 May;113(2):265-74. doi: 10.1046/j.1365-2141.2001.02593.x.
4
Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts.硼替佐米下调霍奇金淋巴瘤细胞系中的生存因子干扰素调节因子 4,并降低霍奇金淋巴瘤相关成纤维细胞的保护活性。
Leuk Lymphoma. 2014 Jan;55(1):149-59. doi: 10.3109/10428194.2013.800196. Epub 2013 Jun 12.
5
Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.重组CD30配体和CD40配体在霍奇金和里德-斯腾伯格细胞上具有共同的生物学活性。
Eur J Immunol. 1995 Jul;25(7):2083-9. doi: 10.1002/eji.1830250742.
6
CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues.正常、反应性及恶性淋巴造血组织中的CD40/CD40配体相互作用
Leuk Lymphoma. 1997 Feb;24(5-6):393-422. doi: 10.3109/10428199709055580.
7
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond.靶向自身免疫疾病中的 CD40-CD40L 通路:体液免疫及其他。
Adv Drug Deliv Rev. 2019 Feb 15;141:92-103. doi: 10.1016/j.addr.2018.12.005. Epub 2018 Dec 13.
8
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.CD40-CD40L 二聚体作为心血管疾病的免疫治疗靶点。
J Cardiovasc Transl Res. 2021 Feb;14(1):13-22. doi: 10.1007/s12265-020-09994-3. Epub 2020 Mar 28.
9
The CD40/CD40L costimulatory pathway in inflammatory bowel disease.炎症性肠病中的CD40/CD40L共刺激通路。
Gut. 2004 Jul;53(7):1035-43. doi: 10.1136/gut.2003.026278.
10
Lymphomagenesis in Hodgkin lymphoma.霍奇金淋巴瘤中的淋巴瘤发生。
Semin Cancer Biol. 2015 Oct;34:14-21. doi: 10.1016/j.semcancer.2015.02.002. Epub 2015 Feb 25.

引用本文的文献

1
Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia.基于拉曼光谱和生物信息学对能够区分弥漫性大B细胞淋巴瘤和慢性淋巴细胞白血病的关键基因及信号通路的鉴定。
Front Immunol. 2025 Feb 25;16:1516946. doi: 10.3389/fimmu.2025.1516946. eCollection 2025.
2
The Relationship of and Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.考虑沙利度胺/硼替佐米治疗的情况下,多发性骨髓瘤患者中[具体基因]和[具体基因]变体与缓解率和生存率的关系
J Clin Med. 2023 Mar 20;12(6):2384. doi: 10.3390/jcm12062384.
3
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model.
从霍奇金淋巴瘤细胞培养中获得的培养基影响成纤维细胞模型的生物物理特性。
Bioengineering (Basel). 2023 Feb 3;10(2):197. doi: 10.3390/bioengineering10020197.
4
Immune Microenvironment in Hematologic Malignancies.血液系统恶性肿瘤中的免疫微环境
Iran J Med Sci. 2023 Jan;48(1):1-3. doi: 10.30476/ijms.2023.48937.
5
Cytokines in Thyroid-Associated Ophthalmopathy.甲状腺相关眼病中的细胞因子。
J Immunol Res. 2022 Nov 14;2022:2528046. doi: 10.1155/2022/2528046. eCollection 2022.
6
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.肿瘤微环境对源自B细胞的淋巴样肿瘤的影响。
Diagnostics (Basel). 2022 Feb 23;12(3):573. doi: 10.3390/diagnostics12030573.
7
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.淋巴瘤中的肿瘤免疫微环境:聚焦表观遗传学
Cancers (Basel). 2022 Mar 13;14(6):1469. doi: 10.3390/cancers14061469.
8
An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment.一种用于三阴性乳腺癌的免疫相关基因预后指数整合了肿瘤免疫微环境的多个方面。
Cancers (Basel). 2021 Oct 25;13(21):5342. doi: 10.3390/cancers13215342.
9
Hodgkin Lymphoma: A Special Microenvironment.霍奇金淋巴瘤:一种特殊的微环境。
J Clin Med. 2021 Oct 12;10(20):4665. doi: 10.3390/jcm10204665.
10
Hodgkin Lymphoma in People Living with HIV.人类免疫缺陷病毒感染者中的霍奇金淋巴瘤
Cancers (Basel). 2021 Aug 29;13(17):4366. doi: 10.3390/cancers13174366.